Pycr1-KO Mouse
Common Name
Pycr1-KO
제품 ID
S-KO-04631
Backgroud
C57BL/6NCya
품종 계통계통 ID
KOCMP-209027-Pycr1-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Pycr1-KO Mouse (카탈로그 번호 S-KO-04631)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Pycr1-KO
품종 계통계통 ID
KOCMP-209027-Pycr1-B6N-VA
유전자명
제품 ID
S-KO-04631
유전자 별칭
P5CR1, P5CR 1
배경
C57BL/6NCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 11
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000170556
NCBI 전사체 ID
NM_001379085
타겟 영역
Exon 3~6
유효 영역 크기
~1.2 kb
유전자 연구 개요
Pycr1, pyrroline-5-carboxylate reductase 1, is the final enzyme in proline biosynthesis, converting pyrroline-5-carboxylate (P5C) to proline. Proline is crucial for maintaining cell redox balance and preventing apoptosis. PYCR1 has been associated with multiple cellular pathways and is of great biological importance, especially in cancer development. Mouse genetic models, such as knockout (KO) models, have been valuable for studying its function [9].
In cancer research, Pycr1 has been found to play oncogenic roles. In colorectal cancer, nuclear IGF1R phosphorylates PYCR1 at Tyrosine 135 under hypoxia, promoting its binding to ELK4 and recruitment to ELK4-targeted gene promoters, thus sustaining tumor growth [1]. In liver cancer, PYCR1 promotes cell growth and metastasis by regulating IRS1 expression through lactylation modification [2]. In breast cancer, cancer-associated fibroblasts (CAFs) require PYCR1-mediated proline synthesis for the deposition of pro-tumorigenic extracellular matrix [3]. In pancreatic, bladder, papillary renal cell, and lung cancers, knockdown of Pycr1 inhibits cell proliferation, invasion, and tumor growth in vivo and in vitro, suggesting its potential as a therapeutic target [4,5,7,8]. In allergic asthma, Pycr1 knockout in mice reduces proline levels in lung tissues, alleviating airway remodeling and EMT by modulating multiple signaling pathways [6].
In conclusion, Pycr1 is essential for proline biosynthesis and has significant impacts on various biological processes, especially in cancer and allergic asthma. The use of Pycr1 KO mouse models has revealed its oncogenic role in multiple cancers, highlighting its potential as a therapeutic target in these disease areas.
References:
1. Zheng, Ke, Sha, Nannan, Hou, Guofang, Jiang, Yuhui, Chen, Tao. 2023. IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia. In Nature communications, 14, 6117. doi:10.1038/s41467-023-41658-z. https://pubmed.ncbi.nlm.nih.gov/37777542/
2. Wang, Haoyu, Xu, Mu, Zhang, Tong, Wang, Qian, Li, John Zhong. . PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. In Clinical and translational medicine, 14, e70045. doi:10.1002/ctm2.70045. https://pubmed.ncbi.nlm.nih.gov/39422696/
3. Kay, Emily J, Paterson, Karla, Riera-Domingo, Carla, Zagnoni, Michele, Zanivan, Sara. 2022. Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix. In Nature metabolism, 4, 693-710. doi:10.1038/s42255-022-00582-0. https://pubmed.ncbi.nlm.nih.gov/35760868/
4. Wang, Huanyu, Mao, Weilin, Lou, Wenhui, Xu, Xuefeng, Zhang, Lei. 2022. PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. In Journal of Cancer, 13, 1501-1511. doi:10.7150/jca.61498. https://pubmed.ncbi.nlm.nih.gov/35371311/
5. Du, Shuangkuan, Sui, Yongjie, Ren, Wei, Zhou, Jiancheng, Du, Chun. 2021. PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling. In Journal of bioenergetics and biomembranes, 53, 247-258. doi:10.1007/s10863-021-09887-3. https://pubmed.ncbi.nlm.nih.gov/33689096/
6. Xu, Tingting, Wu, Zhenzhen, Yuan, Qi, Huang, Mao, Ji, Ningfei. 2023. Proline is increased in allergic asthma and promotes airway remodeling. In JCI insight, 8, . doi:10.1172/jci.insight.167395. https://pubmed.ncbi.nlm.nih.gov/37432745/
7. Wang, Qiu-Li, Liu, Ling. 2019. PYCR1 is Associated with Papillary Renal Cell Carcinoma Progression. In Open medicine (Warsaw, Poland), 14, 586-592. doi:10.1515/med-2019-0066. https://pubmed.ncbi.nlm.nih.gov/31428683/
8. Zhang, Lihong, Zhao, Xinyu, Wang, Enqin, Xu, Hongkun, Zhang, Baojun. 2023. PYCR1 promotes the malignant progression of lung cancer through the JAK-STAT3 signaling pathway via PRODH-dependent glutamine synthesize. In Translational oncology, 32, 101667. doi:10.1016/j.tranon.2023.101667. https://pubmed.ncbi.nlm.nih.gov/37018868/
9. Stum, Morgane G, Tadenev, Abigail L D, Seburn, Kevin L, John, Simon W M, Burgess, Robert W. . Genetic analysis of Pycr1 and Pycr2 in mice. In Genetics, 218, . doi:10.1093/genetics/iyab048. https://pubmed.ncbi.nlm.nih.gov/33734376/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
